Clinical Trial

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

Terminated Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
The study was terminated for business reasons; there were no safety concerns.
Summary
The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking two different forms of tafamidis by mouth under fed conditions.
Protocol Amendment History 2 changes
critical Trial terminated 2026-06-27
critical Recruitment opened 2026-04-25
Trial Details
NCT Number NCT07470866
Lead Sponsor Pfizer
Conditions Healthy
Enrollment 24 participants
Start Date 2026-03-23
Primary Completion 2026-05-12 (estimated)
Study Completion 2026-06-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-26